Playback speed
10 seconds
Chemotherapy-Free Approach in Relapsed/Refractory AML: Antibody-Drug Conjugates, Dual Affinity Re-Targeting (DART) and Bi-Specific T-Cell Engagers (BiTEs)
305 views
October 18, 2019
Login to view comments.
Click here to Login